Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL - PubMed (original) (raw)
. 2001 Jul 13;276(28):26605-13.
doi: 10.1074/jbc.M100740200. Epub 2001 May 10.
Affiliations
- PMID: 11349125
- DOI: 10.1074/jbc.M100740200
Free article
Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL
K Kovalovich et al. J Biol Chem. 2001.
Free article
Abstract
Previous studies showed that following acute carbon tetrachloride (CCl(4)) treatment, interleukin-6 null (IL-6-/-) mice develop increased hepatocellular injury, defective regeneration, delayed wound healing, and increased hepatocyte apoptosis. Pretreatment with IL-6 prior to CCl(4) reduces injury, hepatocyte apoptosis, and accelerates regeneration in both IL-6-/- and +/+ livers. To demonstrate whether IL-6 can prevent liver injury that involves direct stimulation of hepatocyte apoptosis, IL-6-/- and +/+ mice were treated with the Fas agonist, Jo-2 mAb. At low Fas agonist doses, IL-6+/+ mice developed mild hepatic injury and survived, whereas IL-6-/- mice developed severe apoptotic hepatitis within 12 h and died. Pretreatment with IL-6 improved survival in IL-6-/- mice and reduced injury in both IL-6-/- and +/+ livers. The direct anti-apoptotic effects of IL-6 were demonstrated in vitro as IL-6 decreased Fas-mediated apoptosis in both IL-6-/- and +/+ primary hepatocyte cultures, and suggested that IL-6-/- hepatocytes have a pre-existing defect in anti-apoptotic pathways. After Fas activation, IL-6-/- livers demonstrated evidence of both proximal and distal alterations in the apoptotic pathways including elevated caspase 8 and 3 activation-associated fragments, and loss of cytochrome c staining. IL-6-/- livers had reduced pre-existing protein expression of the anti-apoptotic factors Bcl-2 and Bcl-xL as well as more rapid degradation of FLIP following Fas treatment that appeared to be post-transcriptionally regulated. FLIP is a crucial proximal inhibitor of caspase 8 activation in Fas, tumor necrosis factor, and DR3/DR4-mediated apoptosis, and Bcl-2 and Bcl-xL more downstream anti-apoptotic regulators. IL-6 may function as a critical anti-apoptotic factor in the liver by its ability to establish and maintain an adequate level of FLIP and downstream anti-apoptotic factors.
Similar articles
- Dual upregulation of Fas and Bax promotes alloreactive T cell apoptosis in IL-10 gene targeting of cardiac allografts.
Tung TC, Oshima K, Cui G, Laks H, Sen L. Tung TC, et al. Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H964-73. doi: 10.1152/ajpheart.00976.2002. Am J Physiol Heart Circ Physiol. 2003. PMID: 12915385 - Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis.
Schniewind B, Christgen M, Kurdow R, Haye S, Kremer B, Kalthoff H, Ungefroren H. Schniewind B, et al. Int J Cancer. 2004 Mar 20;109(2):182-8. doi: 10.1002/ijc.11679. Int J Cancer. 2004. PMID: 14750167 - FLIP is constitutively hyperexpressed in Fas-resistant U266 myeloma cells, but is not induced by IL-6 in Fas-sensitive RPM18226 cells.
Kim DK, Cho ES, Yoo JH, Um HD. Kim DK, et al. Mol Cells. 2000 Oct 31;10(5):552-6. doi: 10.1007/s10059-000-0552-0. Mol Cells. 2000. PMID: 11101147 - Bid, a critical mediator for apoptosis induced by the activation of Fas/TNF-R1 death receptors in hepatocytes.
Yin XM. Yin XM. J Mol Med (Berl). 2000;78(4):203-11. doi: 10.1007/s001090000099. J Mol Med (Berl). 2000. PMID: 10933582 Review. - Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra.
Ferrer I, Planas AM. Ferrer I, et al. J Neuropathol Exp Neurol. 2003 Apr;62(4):329-39. doi: 10.1093/jnen/62.4.329. J Neuropathol Exp Neurol. 2003. PMID: 12722825 Review.
Cited by
- Effect of Low Doses of Dexamethasone on Experimental Pulmonary Tuberculosis.
Lara-Espinosa JV, Arce-Aceves MF, Barrios-Payán J, Mata-Espinosa D, Lozano-Ordaz V, Becerril-Villanueva E, Ponce-Regalado MD, Hernández-Pando R. Lara-Espinosa JV, et al. Microorganisms. 2023 Jun 10;11(6):1554. doi: 10.3390/microorganisms11061554. Microorganisms. 2023. PMID: 37375056 Free PMC article. - A zebrafish HCT116 xenograft model to predict anandamide outcomes on colorectal cancer.
Maradonna F, Fontana CM, Sella F, Giommi C, Facchinello N, Rampazzo C, Caichiolo M, Hoseinifar SH, Dalla Valle L, Van Doan H, Carnevali O. Maradonna F, et al. Cell Death Dis. 2022 Dec 23;13(12):1069. doi: 10.1038/s41419-022-05523-z. Cell Death Dis. 2022. PMID: 36564370 Free PMC article. - Cellular crosstalk during liver regeneration: unity in diversity.
Shu W, Yang M, Yang J, Lin S, Wei X, Xu X. Shu W, et al. Cell Commun Signal. 2022 Aug 8;20(1):117. doi: 10.1186/s12964-022-00918-z. Cell Commun Signal. 2022. PMID: 35941604 Free PMC article. Review. - A narrative review of liver regeneration-from models to molecular basis.
Huang W, Han N, Du L, Wang M, Chen L, Tang H. Huang W, et al. Ann Transl Med. 2021 Nov;9(22):1705. doi: 10.21037/atm-21-5234. Ann Transl Med. 2021. PMID: 34988214 Free PMC article. Review. - The role of mesenchymal stem cells in liver injury.
Sun H, Shi C, Ye Z, Yao B, Li C, Wang X, Qian Q. Sun H, et al. Cell Biol Int. 2022 Apr;46(4):501-511. doi: 10.1002/cbin.11725. Epub 2022 Feb 17. Cell Biol Int. 2022. PMID: 34882906 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- 1 F32 DK09732-01/DK/NIDDK NIH HHS/United States
- 1 K08 DK 02667-01/DK/NIDDK NIH HHS/United States
- DK 49629/DK/NIDDK NIH HHS/United States
- P30 DK50306/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous